-+ 0.00%
-+ 0.00%
-+ 0.00%

Valneva SE Reports 95% Seroresponse Four Years After Single Dose of Chikungunya Vaccine IXCHIQ® in New Clinical Study

Reuters·10/06/2025 16:03:15

Please log in to view news